Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIIT.L Regulatory News (IIT)

  • There is currently no data for IIT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Scheme of Reconstruction

9 Aug 2022 07:00

RNS Number : 3086V
Independent Investment Trust PLC
09 August 2022
 

 

9 August 2022

 

The Independent Investment Trust plc

Legal Entity Identifier : 213800IYHGJTZJ3MO642

Proposed Combination with Monks Investment Trust plc

 

Introduction

 

The Board of The Independent Investment Trust plc (the "Company" or "IIT") is pleased to announce that it has agreed heads of terms with the Board of Monks Investment Trust plc ("Monks") in respect of a future combination with Monks to be effected by way of a scheme of reconstruction under Section 110 of the Insolvency Act 1986 and a voluntary winding up of the Company (the "Scheme"). IIT shareholders will be able to elect either to receive new ordinary shares issued by Monks and / or realise part, or all, of their holding for cash.

 

Background to the Scheme

 

Max Ward, the Company's Managing Director and full-time portfolio manager, recently informed the Board of IIT that he wished to retire from his role. Given the impact that Max's retirement would have on the Company, the Board carefully considered the various options available and decided that a combination with Monks offered the greatest benefit to IIT shareholders.

 

The Global Alpha team within Baillie Gifford, which took over the management of Monks in 2015, has a strong long term record, and the wide diversification of the portfolio, beyond the resources of IIT, is a feature which the Board of IIT considers attractive against an uncertain geopolitical background which may prove persistent. The scale of Monks, with assets of £2,495 million at 30 June 2022 and no dominant shareholders, allows for a liquid market in its shares.

 

Benefits of the Scheme to IIT Shareholders

 

The Board believes that the Scheme has a number of benefits for IIT shareholders:

· Ability to stay invested in a tax efficient manner: As part of the Scheme, IIT shareholders will have the option of a rollover into Monks without triggering capital gains tax.

· Opportunity for full cash realisation: An unlimited cash exit option will give shareholders the option to realise all or part of their holding at a level near to liquidation value should they so wish.

· Attractive look-through value for shareholders: Monks's shares currently trade at a tighter discount to their underlying net asset value when compared to IIT and thus provide an attractive look-through value for IIT shareholders.

· Continuity of investment proposition: Shareholders will be able to maintain exposure to similar investment objectives but with a more diversified portfolio.

· Baillie Gifford cost contribution: Baillie Gifford will offer a cost contribution by way of a six month fee waiver based on the quantum of assets rolling over to Monks. This will be for the benefit of all shareholders of the enlarged Monks.

· Increase in scale: An enlarged Monks will allow fixed costs to be spread over a larger cost base, alongside improving liquidity and aiding marketing.

 

Further details on the Scheme

 

The Scheme will be effected by way of a scheme of reconstruction under Section 110 of the Insolvency Act 1986, under which IIT shareholders will be able to elect either to receive new ordinary shares issued by Monks (the "Rollover Option") and / or realise part, or all, of their holding for cash (the "Cash Option").

 

The Scheme will be undertaken on a Formula Asset Value to Formula Asset Value ("FAV") basis. The FAV of IIT (the "IIT FAV") and the FAV of Monks (the "Monks FAV") for the purposes of the Scheme will be calculated in accordance with the respective company's normal accounting policies and take into account their own respective costs, with the exception of stamp duty and listing fees which will be paid by the enlarged Monks, and any dividends declared but not paid. The uplift in FAV delivered by the Cash Option will be for the benefit of the IIT rollover shareholders.

 

IIT shareholders who elect to realise all or part of their holding in the Company for cash will receive an amount in cash equal to the IIT FAV per share, less 2 per cent., multiplied by the number of IIT shares they own. For the avoidance of doubt, there will be no limit on the number of IIT Shares which may be elected for the Cash Option.

 

The Scheme will be subject to approval by the shareholders of both companies in addition to regulatory and tax approvals. In accordance with customary practice for such transactions involving investment trusts, the City Code on Takeovers and Mergers is not expected to apply to the Scheme. A timetable and further details of the Scheme will be announced in due course.

 

The directors of IIT, who own circa 24.3% of the company's equity, all intend to elect for the Rollover Option to the full extent of their holdings and will also recommend the resolutions which will be put to shareholders proposing the Scheme.

 

The Company will pay a pre-liquidation interim dividend to the extent required in order to maintain investment trust status.

Overview of Monks

 

Summary

 

Monks is a United Kingdom-based investment trust whose investment objective is to invest across the globe to achieve capital growth, which takes priority over income and dividends. This is pursued through applying a patient approach to investment, principally from a differentiated, actively managed global equity portfolio containing a diversified range of growth stocks - companies with above average earnings growth - which Monks expects to hold for around five years on average. Investments are made on an unconstrained basis. The portfolio, which includes stocks with a range of different growth profiles, will typically contain 100+ stocks from around the world and Monks should not be viewed as a proxy for any index. As at 30 June 2022, Monks had total assets of £2,495 million.

 

Monks is managed by Baillie Gifford & Co, an independent fund management group, which has around £230 billion under management and advice.

 

Following completion of the Scheme, it is intended that the Monks portfolio will continue to be managed on the same basis as it is currently. In particular, the Monks investment policy and investment objective will not be amended in connection with the Scheme and the portfolio will continue to be managed by Spencer Adair, supported by Malcolm MacColl and Baillie Gifford's Global Alpha team.

 

Management fee and ongoing costs

 

The annual management fee is 0.45% on the first £750 million of total assets, 0.33% on the next £1 billion of total assets and 0.30% on the remaining total assets. The total ongoing charges ratio for the year to 30 April 2022 was 0.40%, down from 0.43% in the prior year.

 

Board Composition

 

The Board of Monks currently comprises five Directors all of whom are non-executive. It has been agreed that none of the IIT Directors will be joining the Monks Board as part of the Scheme and, accordingly, the Board of Monks will continue to consist of the five incumbent Directors upon completion of the Scheme.

Expected timetable

 

It is currently envisaged that a shareholder circular and notice of the general meeting setting out the details of the Scheme and seeking shareholder approval for the cash exit and liquidation will be sent to shareholders in late September 2022. The relevant general meetings are expected to be held in October 2022.

 

 

For further information please contact:

 

Independent Investment Trust plc

+44 (0) 131 558 9434

Douglas McDougall

 

J.P. Morgan Cazenove

+44 (0) 207 742 4000

William Simmonds

Rupert Budge

 

 

Important Information

 

 

This announcement contains information that is inside information for the purposes of the Market Abuse Regulation (EU) No. 596/2014.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFLFVETVITIIF
Date   Source Headline
3rd Nov 202210:45 amRNSNet Asset Value(s)
2nd Nov 202210:41 amRNSNet Asset Value(s)
1st Nov 202212:33 pmRNSNet Asset Value(s)
31st Oct 20222:02 pmRNSResult of Meeting
31st Oct 202210:48 amRNSNet Asset Value(s)
28th Oct 202210:59 amRNSNet Asset Value(s)
27th Oct 202210:35 amRNSNet Asset Value(s)
26th Oct 202210:57 amRNSNet Asset Value(s)
25th Oct 202212:01 pmRNSNet Asset Value(s)
24th Oct 20225:30 pmRNSIndependent Investment Trust PLC
24th Oct 202210:21 amRNSNet Asset Value(s)
21st Oct 202211:17 amRNSNet Asset Value(s)
20th Oct 202211:06 amRNSNet Asset Value(s)
19th Oct 202210:05 amRNSNet Asset Value(s)
18th Oct 202211:17 amRNSNet Asset Value(s)
17th Oct 202211:21 amRNSNet Asset Value(s)
17th Oct 202211:21 amRNSNet Asset Value(s)
14th Oct 202212:32 pmRNSNet Asset Value(s)
13th Oct 202210:32 amRNSNet Asset Value(s)
12th Oct 202210:18 amRNSNet Asset Value(s)
11th Oct 202210:48 amRNSNet Asset Value(s)
10th Oct 202211:03 amRNSNet Asset Value(s)
7th Oct 202210:12 amRNSNet Asset Value(s)
6th Oct 202211:39 amRNSPre-liquidation interim dividend
6th Oct 202211:33 amRNSPublication of a Circular
6th Oct 202210:15 amRNSNet Asset Value(s)
5th Oct 202210:43 amRNSNet Asset Value(s)
4th Oct 202210:21 amRNSNet Asset Value(s)
3rd Oct 202211:48 amRNSNet Asset Value(s)
30th Sep 202212:33 pmRNSNet Asset Value(s)
29th Sep 202211:00 amRNSNet Asset Value(s)
28th Sep 202212:18 pmRNSNet Asset Value(s)
27th Sep 202210:44 amRNSNet Asset Value(s)
26th Sep 202211:39 amRNSNet Asset Value(s)
23rd Sep 202211:18 amRNSNet Asset Value(s)
22nd Sep 202210:52 amRNSNet Asset Value(s)
21st Sep 202211:53 amRNSNet Asset Value(s)
20th Sep 202212:37 pmRNSNet Asset Value(s)
20th Sep 202210:42 amRNSNet Asset Value(s)
16th Sep 202211:09 amRNSNet Asset Value(s)
15th Sep 202211:19 amRNSNet Asset Value(s)
14th Sep 202210:31 amRNSNet Asset Value(s)
13th Sep 202211:26 amRNSNet Asset Value(s)
12th Sep 202210:47 amRNSNet Asset Value(s)
9th Sep 202211:24 amRNSNet Asset Value(s)
8th Sep 202210:04 amRNSNet Asset Value(s)
7th Sep 202211:10 amRNSNet Asset Value(s)
6th Sep 202211:19 amRNSNet Asset Value(s)
5th Sep 202210:52 amRNSNet Asset Value(s)
2nd Sep 202212:43 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.